Skip to contentC
cbdMD, Inc.
C
YCBDcbdMD, Inc. Q1 2025 · 10-Q
Revenue$5.11M$5.11M−4.9% vs Q1 2024 Net Income$15.10K$15.10KN/M vs Q1 2024 EPS, diluted—
Gross Profit$3,400,609−4.4% Operating Income-$86,272N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
cbdMD, Inc. · CIK 1644903 · Engraved from SEC EDGAR
Operating Cash Flow-$317,949N/M Free Cash Flowderived-$482,336N/M Margins · derivedGross margin66.5%+0.3 pt vs Q1 2024
Operating margin-1.7%+18.1 pt vs Q1 2024
Net margin0.3%+18.8 pt vs Q1 2024
ended Dec 31, 2024 · filed Feb 13, 2025 · 44 d after period end